Procalcitonin for the diagnosis of invasive candidiasis: What is the evidence?

Risultato della ricerca: Article

3 Citazioni (Scopus)

Abstract

Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.
Lingua originaleEnglish
pagine (da-a)58-
Numero di pagine2
RivistaJournal of Intensive Care
Volume5
Stato di pubblicazionePublished - 2017

Fingerprint

Invasive Candidiasis
Calcitonin
Candida
Sepsis
Biomarkers
Anti-Bacterial Agents
Infection
Serum
Therapeutics

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

Cita questo

@article{66b643a1f00743e7aedfd0a80c0b941b,
title = "Procalcitonin for the diagnosis of invasive candidiasis: What is the evidence?",
abstract = "Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.",
keywords = "Candida spp., Critical Care and Intensive Care Medicine, Invasive candidiasis, Procalcitonin, Sepsis",
author = "Andrea Cortegiani and Antonino Giarratano and Raineri, {Santi Maurizio} and Filippo Vitale and Pasquale Iozzo",
year = "2017",
language = "English",
volume = "5",
pages = "58--",
journal = "Journal of Intensive Care",
issn = "2052-0492",
publisher = "Springer International Publishing AG",

}

TY - JOUR

T1 - Procalcitonin for the diagnosis of invasive candidiasis: What is the evidence?

AU - Cortegiani, Andrea

AU - Giarratano, Antonino

AU - Raineri, Santi Maurizio

AU - Vitale, Filippo

AU - Iozzo, Pasquale

PY - 2017

Y1 - 2017

N2 - Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.

AB - Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.

KW - Candida spp.

KW - Critical Care and Intensive Care Medicine

KW - Invasive candidiasis

KW - Procalcitonin

KW - Sepsis

UR - http://hdl.handle.net/10447/272651

UR - http://www.jintensivecare.com/

M3 - Article

VL - 5

SP - 58-

JO - Journal of Intensive Care

JF - Journal of Intensive Care

SN - 2052-0492

ER -